Corinne E Metzger1, Elizabeth A Swallow1, Alexander J Stacy1, Matthew R Allen2. 1. Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, IN, United States. 2. Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, IN, United States; Department of Medicine - Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, United States; Department of Biomedical Engineering, Indiana University Purdue University of Indianapolis, Indianapolis, IN, United States; Roudebush Veterans Administration Medical Center, Indianapolis, IN, United States. Electronic address: matallen@iu.edu.
Abstract
Chronic kidney disease (CKD) leads to loss of cortical bone through cortical thinning and the development of cortical porosity. The goal of this current study was to assess cortical bone alterations to adenine-induced chronic kidney disease (CKD) in two strains of mice with known genetic differences in cortical thickness. We hypothesized that C3H mice with thicker cortices and baseline levels of intracortical remodeling would have greater cortical porosity in response to adenine-induced CKD compared to B6 animals. METHODS: Female C57BL/6 J (B6) and C3H/Hej (C3H) at 16-weeks of age were given a diet with 0.2% adenine to induce CKD for 6 weeks followed by a control diet for 4 weeks. Age- and strain-matched controls were fed the control diet without adenine for the 10-week period (n = 8 per group per strain). RESULTS: Both strains of adenine-fed mice had elevated blood urea nitrogen, demonstrating compromised kidney function, compared to strain-matched controls, but only B6 adenine mice had statistically higher parathyroid hormone (PTH), greater cortical porosity, high bone turnover rate, a greater percentage of osteocytes positive for RANKL and IL-17, and lower osteocyte apoptosis compared to B6 controls. C3H mice had intracortical remodeling present in both control and adenine mice, while B6 mice had intracortical remodeling present only in adenine mice. Adenine mice of both strains had lower cortical thickness and a higher percentage of osteocytes positive for TNF-α compared to controls. CONCLUSION: While both strains of mice had biochemical markers of kidney disease, only B6 mice developed a phenotype with significantly elevated PTH, high bone turnover, and cortical porosity development. This work, in a model of progressive CKD, further confirms the role of chronically elevated PTH in the development of cortical porosity and demonstrates adenine-induced increases in PTH contribute to intracortical remodeling in B6 mice. Adenine-induced changes that occurred in both strains of mice, notably lower cortical thickness and a higher percentage of osteocytes expressing TNF-α, indicate potential PTH-independent responses to CKD. Published by Elsevier Inc.
Chronic kidney disease (CKD) leads to loss of cortical bone through cortical thinning and the development of cortical porosity. The goal of this current study was to assess cortical bone alterations to adenine-induced chronic kidney disease (CKD) in two strains of mice with known genetic differences in cortical thickness. We hypothesized that C3H mice with thicker cortices and baseline levels of intracortical remodeling would have greater cortical porosity in response to adenine-induced CKD compared to B6 animals. METHODS: Female C57BL/6 J (B6) and C3H/Hej (C3H) at 16-weeks of age were given a diet with 0.2% adenine to induce CKD for 6 weeks followed by a control diet for 4 weeks. Age- and strain-matched controls were fed the control diet without adenine for the 10-week period (n = 8 per group per strain). RESULTS: Both strains of adenine-fed mice had elevated blood urea nitrogen, demonstrating compromised kidney function, compared to strain-matched controls, but only B6 adenine mice had statistically higher parathyroid hormone (PTH), greater cortical porosity, high bone turnover rate, a greater percentage of osteocytes positive for RANKL and IL-17, and lower osteocyte apoptosis compared to B6 controls. C3H mice had intracortical remodeling present in both control and adenine mice, while B6 mice had intracortical remodeling present only in adenine mice. Adenine mice of both strains had lower cortical thickness and a higher percentage of osteocytes positive for TNF-α compared to controls. CONCLUSION: While both strains of mice had biochemical markers of kidney disease, only B6 mice developed a phenotype with significantly elevated PTH, high bone turnover, and cortical porosity development. This work, in a model of progressive CKD, further confirms the role of chronically elevated PTH in the development of cortical porosity and demonstrates adenine-induced increases in PTH contribute to intracortical remodeling in B6 mice. Adenine-induced changes that occurred in both strains of mice, notably lower cortical thickness and a higher percentage of osteocytes expressing TNF-α, indicate potential PTH-independent responses to CKD. Published by Elsevier Inc.
Authors: Chao Yang Li; Mitchell B Schaffler; Henock T Wolde-Semait; Christopher J Hernandez; Karl J Jepsen Journal: J Bone Miner Res Date: 2005-08-22 Impact factor: 6.741
Authors: Anoop Shankar; Liping Sun; Barbara E K Klein; Kristine E Lee; Paul Muntner; F Javier Nieto; Michael Y Tsai; Karen J Cruickshanks; Carla R Schubert; Peter C Brazy; Josef Coresh; Ronald Klein Journal: Kidney Int Date: 2011-08-24 Impact factor: 10.612
Authors: Daniel Amblard; Marie-Hélène Lafage-Proust; Andres Laib; Thierry Thomas; Peter Rüegsegger; Christian Alexandre; Laurence Vico Journal: J Bone Miner Res Date: 2003-03 Impact factor: 6.741
Authors: P L Kimmel; T M Phillips; S J Simmens; R A Peterson; K L Weihs; S Alleyne; I Cruz; J A Yanovski; J H Veis Journal: Kidney Int Date: 1998-07 Impact factor: 10.612
Authors: Jau-Yi Li; Patrizia D'Amelio; Jerid Robinson; Lindsey D Walker; Chiara Vaccaro; Tao Luo; Abdul Malik Tyagi; Mingcan Yu; Michael Reott; Francesca Sassi; Ilaria Buondonno; Jonathan Adams; M Neale Weitzmann; Giovanni Carlo Isaia; Roberto Pacifici Journal: Cell Metab Date: 2015-10-08 Impact factor: 27.287
Authors: Corinne E Metzger; S Anand Narayanan; Jon P Elizondo; Anne Michal Carter; David C Zawieja; Harry A Hogan; Susan A Bloomfield Journal: Sci Rep Date: 2019-10-22 Impact factor: 4.379
Authors: Guaraciaba O Ferrari; Juliana C Ferreira; Raquel T Cavallari; Katia R Neves; Luciene M dos Reis; Wagner V Dominguez; Elizabeth C Oliveira; Fabiana G Graciolli; Jutta Passlick-Deetjen; Vanda Jorgetti; Rosa M A Moysés Journal: BMC Nephrol Date: 2014-05-03 Impact factor: 2.388
Authors: Elizabeth A Swallow; Corinne E Metzger; Neal X Chen; Joseph M Wallace; Samantha P Tippen; Rachel Kohler; Sharon M Moe; Matthew R Allen Journal: Bone Rep Date: 2022-02-07
Authors: Corinne E Metzger; Christopher L Newman; Samantha P Tippen; Natalie T Golemme; Neal X Chen; Sharon M Moe; Matthew R Allen Journal: Bone Rep Date: 2022-08-17